-
Viagra / Cialis / Levitra: Prostate Cancer Recurrence When Used After Radical Prostatectomy Surgery
Researchers Surprised By Their Finding As Earlier Medical Studies Suggested Anticancer Effect In Prostate (Posted by Tom Lamb at DrugInjuryWatch.com) Findings about increased cancer risks being associated with the use of erectile dysfunction (ED) drugs such as…
-
UK Drug Safety Regulator Issues New Warnings About The Use Of Depakote / Depacon / Depakene By Women During Pregnancy
Updates Information About Extent Of Serious Developmental Disorders Such As Autism Spectrum Disorders (ASD) As Well As Congenital Malformations And Birth Defects Like Spina Bifida (Posted by Tom Lamb at DrugInjuryWatch.com) Depakote, Depakote CP, and Depakote ER (divalproex sodium),…
-
Pancreatic Cancer As A Side Effect Of Diabetes Drugs Bydureon, Byetta, Januvia, And Victoza
Health Canada Currently Conducting Epidemiological Study Of These Incretin-Based Type 2 Diabetes Medications To Assess This Potential Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com)From the October 2014 edition of the Canadian Adverse Reaction Newsletter we…
-
A French Medical Study Provides More Support For Apparent Link Between Benicar With Chronic Severe Diarrhea And Substantial Weight Loss Side Effects
Researchers Found An Almost 10-Times Increased Risk Of Severe Intestinal Malabsorption Associated With Benicar After 2-Years Use Compared To Some Other Blood Pressure Medications (Posted by Tom Lamb at DrugInjuryWatch.com) We continue to hear about patients who…
-
Cialis / Levitra / Viagra – Melanoma: Possible Drug Safety Issue Was Raised And Left Open In A 2011 Medical Journal Article
Erectile Dysfunction (ED) Drugs And Pulmonary Arterial Hypertension (PAH) Medications May Cause Increased Rate Of Melanoma Metastasis (Posted by Tom Lamb at DrugInjuryWatch.com) To start, we get our background facts and some commentary from "Hard Times for…
-
Xolair Is Associated With Higher Than Expected Reporting Of Arterial Thrombotic Events Such As Strokes And Cardiovascular Deaths
While European Drug Regulators Have Been Concerned About This Aspect Of Xolair Safety, FDA Has No Warning About Arteriothrombotic Risks Of Xolair (Posted by Tom Lamb at DrugInjuryWatch.com)In September 2014 the FDA issued an update about its…
